Kane Biotech Inc. appointed Rashieda Gluck to its board.
Gluck is Aurinia Pharmaceuticals Inc.'s senior vice president of global clinical operations.
Winnipeg, Manitoba-based Kane Biotech develops technologies and products that prevent and remove microbial biofilms.
